206 related articles for article (PubMed ID: 15257704)
21. Cytogenetic, morphological, and immunophenotypic patterns in Omani patients with de novo acute myeloid leukemia.
Udayakumar AM; Pathare AV; Al-Kindi S; Khan H; Rehmen JU; Zia F; Al-Ghazaly A; Nusrut N; Khan MI; Wali YA; Al-Lamki Z; Dennison D; Raeburn JA
Cancer Genet Cytogenet; 2007 Sep; 177(2):89-94. PubMed ID: 17854660
[TBL] [Abstract][Full Text] [Related]
22. Translocation (10;11)(p12;q23) in childhood acute myeloid leukemia: incidence and complex mechanism.
Stasevich I; Utskevich R; Kustanovich A; Litvinko N; Savitskaya T; Chernyavskaya S; Saharova O; Aleinikova O
Cancer Genet Cytogenet; 2006 Sep; 169(2):114-20. PubMed ID: 16938568
[TBL] [Abstract][Full Text] [Related]
23. [Clinical and laboratory studies on childhood acute leukemia with 11q23 abnormalities].
He YX; Xue YQ; He J; Zhang XL; Ji ZH; Huang YP; Zhu XM; He HL; Chai YH; Zhu LL
Zhonghua Xue Ye Xue Za Zhi; 2003 Jul; 24(7):358-61. PubMed ID: 12941190
[TBL] [Abstract][Full Text] [Related]
24. Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group.
Tomizawa D; Tabuchi K; Kinoshita A; Hanada R; Kigasawa H; Tsukimoto I; Tsuchida M;
Pediatr Blood Cancer; 2007 Aug; 49(2):127-32. PubMed ID: 16807916
[TBL] [Abstract][Full Text] [Related]
25. Detailed analysis of FLT3 expression levels in acute myeloid leukemia.
Kuchenbauer F; Kern W; Schoch C; Kohlmann A; Hiddemann W; Haferlach T; Schnittger S
Haematologica; 2005 Dec; 90(12):1617-25. PubMed ID: 16330434
[TBL] [Abstract][Full Text] [Related]
26. Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98.
Creutzig U; Zimmermann M; Lehrnbecher T; Graf N; Hermann J; Niemeyer CM; Reiter A; Ritter J; Dworzak M; Stary J; Reinhardt D
J Clin Oncol; 2006 Sep; 24(27):4499-506. PubMed ID: 16983120
[TBL] [Abstract][Full Text] [Related]
27. Acute myelogenous leukaemia in children under 2 years--experiences of the West German AML studies BFM-78, -83 and -87. AML-BFM Study Group.
Vormoor J; Ritter J; Creutzig U; Boos J; Heyen P; Ludwig WD; Harbott J; Löffler H; Schellong G
Br J Cancer Suppl; 1992 Aug; 18():S63-7. PubMed ID: 1503929
[TBL] [Abstract][Full Text] [Related]
28. Influence of cytogenetic abnormalities on outcome after allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission.
Chalandon Y; Barnett MJ; Horsman DE; Conneally EA; Nantel SH; Nevill TJ; Nitta J; Shepherd JD; Sutherland HJ; Toze CL; Hogge DE
Biol Blood Marrow Transplant; 2002; 8(8):435-43. PubMed ID: 12234169
[TBL] [Abstract][Full Text] [Related]
29. The role of MDR-related proteins in the prognosis of adult acute myeloid leukaemia (AML) with normal karyotype.
Damiani D; Tiribelli M; Raspadori D; Michelutti A; Gozzetti A; Calistri E; Candoni A; Chiarvesio A; Lenoci M; Russo D; Fanin R
Hematol Oncol; 2007 Mar; 25(1):38-43. PubMed ID: 17200981
[TBL] [Abstract][Full Text] [Related]
30. Therapy-related myeloid leukaemia: a model for leukemogenesis in humans.
Larson RA; Le Beau MM
Chem Biol Interact; 2005 May; 153-154():187-95. PubMed ID: 15935816
[TBL] [Abstract][Full Text] [Related]
31. Acute leukaemias of ambiguous lineage in children: characterization, prognosis and therapy recommendations.
Gerr H; Zimmermann M; Schrappe M; Dworzak M; Ludwig WD; Bradtke J; Moericke A; Schabath R; Creutzig U; Reinhardt D
Br J Haematol; 2010 Apr; 149(1):84-92. PubMed ID: 20085575
[TBL] [Abstract][Full Text] [Related]
32. [Analysis of prognostic variables in childhood acute myeloid leukemia].
Gu LJ; Tie LJ; Xue HL; Tang JY; Chen J; Pan C; Chen J; Ye H; Wang YP; Dong L
Zhonghua Xue Ye Xue Za Zhi; 2006 Jan; 27(1):10-3. PubMed ID: 16732931
[TBL] [Abstract][Full Text] [Related]
33. Identification of a group of AML/MDS patients with a relatively favorable prognosis who have chromosome 5 and/or 7 abnormalities.
Estey EH; Pierce S; Keating MJ
Haematologica; 2000 Mar; 85(3):246-9. PubMed ID: 10702811
[TBL] [Abstract][Full Text] [Related]
34. [Cytogenetic and clinical study of myeloid leukemia].
Jiang SH; Shi WY; Liu H; Song GQ; Sun GX; Lu W; Liu DF
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Oct; 24(5):571-3. PubMed ID: 17922430
[TBL] [Abstract][Full Text] [Related]
35. [Analyses of karyotypic characteristics and prognosis in pediatric acute myeloblastic leukemia].
Ruan M; Wang YQ; Zhang L; Zou Y; Zhu XF
Zhonghua Xue Ye Xue Za Zhi; 2012 Sep; 33(9):725-8. PubMed ID: 23336225
[TBL] [Abstract][Full Text] [Related]
36. Acute leukaemia in children with Down syndrome: a population-based Nordic study.
Zeller B; Gustafsson G; Forestier E; Abrahamsson J; Clausen N; Heldrup J; Hovi L; Jonmundsson G; Lie SO; Glomstein A; Hasle H;
Br J Haematol; 2005 Mar; 128(6):797-804. PubMed ID: 15755283
[TBL] [Abstract][Full Text] [Related]
37. Various distinctive cytogenetic abnormalities in patients with acute myeloid leukaemia aged 60 years and older express adverse prognostic value: results from a prospective clinical trial.
van der Holt B; Breems DA; Berna Beverloo H; van den Berg E; Burnett AK; Sonneveld P; Löwenberg B
Br J Haematol; 2007 Jan; 136(1):96-105. PubMed ID: 17129222
[TBL] [Abstract][Full Text] [Related]
38. Long-term outcome of intensive chemotherapy for adults with de novo acute myeloid leukaemia (AML): the nationwide AML-92 study by the Finnish Leukaemia Group.
Koistinen P; Räty R; Itälä M; Jantunen E; Koivunen E; Nousiainen T; Pelliniemi TT; Remes K; Ruutu T; Savolainen ER; Siitonen T; Silvennoinen R; Volin L; Elonen E;
Eur J Haematol; 2007 Jun; 78(6):477-86. PubMed ID: 17391337
[TBL] [Abstract][Full Text] [Related]
39. Acute myeloid leukemia with translocation (8;21) or inversion (16) in elderly patients treated with conventional chemotherapy: a collaborative study of the French CBF-AML intergroup.
Prébet T; Boissel N; Reutenauer S; Thomas X; Delaunay J; Cahn JY; Pigneux A; Quesnel B; Witz F; Thépot S; Ugo V; Terre C; Recher C; Tavernier E; Hunault M; Esterni B; Castaigne S; Guilhot F; Dombret H; Vey N; ; ;
J Clin Oncol; 2009 Oct; 27(28):4747-53. PubMed ID: 19720919
[TBL] [Abstract][Full Text] [Related]
40. [Effectiveness analysis of HA based triple-drug regimen as induction chemotherapy in the treatment of acute myeloid leukemia and its relationship with karyotype].
Mi YC; Xue YP; Yu WJ; Liu SH; Zhao YZ; Meng QX; Bian SG; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2005 Dec; 26(12):705-9. PubMed ID: 16620570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
